Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | Abilify Maintena 960mg/3.2ml prolonged-release suspension for injection pre-filled syringes (Otsuka Pharmaceuticals (U.K.) Ltd) |
| BNF code | 0402020ADBBACAC |
| Virtual Medicinal Product | Aripiprazole 960mg/3.2ml prolonged-release suspension for injection pre-filled syringes |
| Name | Abilify Maintena 960mg/3.2ml prolonged-release suspension for injection pre-filled syringes |
| Abbreviated name | Abilify Maintena 960mg/3.2ml prolonged-release inj pfs |
| Supplier | Otsuka Pharmaceuticals (U.K.) Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intramuscular |
| Actual Medicinal Product Packs | |
| Abilify Maintena 960mg/3.2ml prolonged-release suspension for injection pre-filled syringes (Otsuka Pharmaceuticals (U.K.) Ltd) 1 pre-filled disposable injection | |
dm+d data retrieved from TRUD: release NHSBSA_11.1.0_20241111000001, imported on 12th November 2024 at 03:53:04.